Frontline Decisions in NDMM: Case Discussion on Regimen Selection and MRD-Guided Management

Despite major therapeutic advances in the treatment of newly diagnosed multiple myeloma (NDMM), frontline management remains highly complex, creating an urgent need for practical, case-based education. While newer anti-CD38–based quadruplet regimens achieve deeper responses and higher measurable…

Price

Free

Accredited provider:

i3 Health

Learning platform:

IQ Apparatus

Release date

August 19, 2026

Expires

August 18, 2027